Eye-scanning device is designed to detect Alzheimer's disease

07/16/2013 | American City Business Journals

Cognoptix has created a noninvasive eye-scanning device, called SAPPHIRE II, that uses a specific beta amyloid signature in the eye to determine whether a patient is at risk for Alzheimer's disease. The Acton, Mass.-based company will release information on the device Wednesday at a conference in Boston.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC